七种流行结构化饮食方案对心血管风险升高患者死亡率和主要心血管事件风险的比较:系统综述与网络Meta分析
该系统综述与网络Meta分析纳入40项随机对照试验共35548名心血管风险升高患者,比较七种命名饮食方案与最小干预的效果。中等确定性证据显示,地中海饮食方案在降低全因死亡、心血管死亡、卒中和非致死性心肌梗死方面优于最小干预;低脂方案在降低全因死亡和非致死性心肌梗死方面优于最小干预;其余五种方案通常与最小干预相比获益很小或没有获益。
要点
- 地中海饮食方案优于最小干预,可降低全因死亡、心血管死亡、卒中和非致死性心肌梗死风险。
- 低脂方案优于最小干预,可降低全因死亡和非致死性心肌梗死风险。
- 其余五种命名饮食方案与最小干预相比通常获益很小或没有获益。
核心结论
- 中等确定性证据表明,促进地中海饮食和低脂饮食的方案(无论是否包含体力活动或其他干预)可降低心血管风险升高患者的全因死亡率和非致死性心肌梗死。
- 地中海方案还可能降低卒中风险;其他命名饮食方案通常不优于最小干预。
研究设计与样本
- 系统综述与随机对照试验网络Meta分析,检索AMED、CENTRAL、Embase、Medline、CINAHL和ClinicalTrials.gov至2021年9月。
- 纳入40项随机对照试验,共35548名心血管风险升高患者,比较七种命名饮食方案与最小干预或替代方案,随访至少九个月并报告死亡率或主要心血管事件。
- 饮食方案除饮食干预外还可包括运动、行为支持和其他二级干预如药物治疗;采用随机效应网络Meta分析和GRADE方法评价证据确定性。
主要发现
- 地中海饮食方案与最小干预相比:全因死亡OR 0.72(95%CI 0.56至0.92),中危患者五年随访每1000人减少17例;心血管死亡OR 0.55(95%CI 0.39至0.78),每1000人减少13例;卒中OR 0.65(95%CI 0.46至0.93),每1000人减少7例;非致死性心肌梗死OR 0.48(95%CI 0.36至0.65),每1000人减少17例。
- 低脂方案与最小干预相比:全因死亡OR 0.84(95%CI 0.74至0.95),每1000人减少9例;非致死性心肌梗死OR 0.77(95%CI 0.61至0.96),每1000人减少7例。
- 两种饮食方案的绝对效应在高危患者中更为明显;地中海方案与低脂方案在死亡率或非致死性心肌梗死方面无令人信服的差异。
- 其余五种饮食方案与最小干预相比通常获益很小或没有获益,证据确定性通常为低至中等。
关键数值与推荐
- 纳入七种命名饮食方案:低脂(18项研究)、地中海(12项)、极低脂(6项)、改良脂肪(4项)、低脂联合低钠(3项)、Ornish(3项)、Pritikin(1项)。
- 主要结局为全因死亡、心血管死亡和个体心血管事件(卒中、非致死性心肌梗死、非计划心血管干预)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the relative efficacy of structured named diet and health behaviour programmes (dietary programmes) for prevention of mortality and major cardiovascular events in patients at increased risk of cardiovascular disease. DESIGN: Systematic review and network meta-analysis of randomised controlled trials. DATA SOURCES: AMED (Allied and Complementary Medicine Database), CENTRAL (Cochrane Central Register of Controlled Trials), Embase, Medline, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and ClinicalTrials.gov were searched up to September 2021. STUDY SELECTION: Randomised trials of patients at increased risk of cardiovascular disease that compared dietary programmes with minimal intervention (eg, healthy diet brochure) or alternative programmes with at least nine months of follow-up and reporting on mortality or major cardiovascular events (such as stroke or non-fatal myocardial infarction). In addition to dietary intervention, dietary programmes could also include exercise, behavioural support, and other secondary interventions such as drug treatment. OUTCOMES AND MEASURES: All cause mortality, cardiovascular mortality, and individual cardiovascular events (stroke, non-fatal myocardial infarction, and unplanned cardiovascular interventions). REVIEW METHODS: Pairs of reviewers independently extracted data and assessed risk of bias. A random effects network meta-analysis was performed using a frequentist approach and grading of recommendations assessment, development and evaluation (GRADE) methods to determine the certainty of evidence for each outcome. RESULTS: 40 eligible trials were identified with 35 548 participants across seven named dietary programmes (low fat, 18 studies; Mediterranean, 12; very low fat, 6; modified fat, 4; combined low fat and low sodium, 3; Ornish, 3; Pritikin, 1). At last reported follow-up, based on moderate certainty evidence, Mediterranean dietary programmes proved superior to minimal intervention for the prevention of all cause mortality (odds ratio 0.72, 95% confidence interval 0.56 to 0.92; patients at intermediate risk: risk difference 17 fewer per 1000 followed over five years), cardiovascular mortality (0.55, 0.39 to 0.78; 13 fewer per 1000), stroke (0.65, 0.46 to 0.93; 7 fewer per 1000), and non-fatal myocardial infarction (0.48, 0.36 to 0.65; 17 fewer per 1000). Based on moderate certainty evidence, low fat programmes proved superior to minimal intervention for prevention of all cause mortality (0.84, 0.74 to 0.95; 9 fewer per 1000) and non-fatal myocardial infarction (0.77, 0.61 to 0.96; 7 fewer per 1000). The absolute effects for both dietary programmes were more pronounced for patients at high risk. There were no convincing differences between Mediterranean and low fat programmes for mortality or non-fatal myocardial infarction. The five remaining dietary programmes generally had little or no benefit compared with minimal intervention typically based on low to moderate certainty evidence. CONCLUSIONS: Moderate certainty evidence shows that programmes promoting Mediterranean and low fat diets, with or without physical activity or other interventions, reduce all cause mortality and non-fatal myocardial infarction in patients with increased cardiovascular risk. Mediterranean programmes are also likely to reduce stroke risk. Generally, other named dietary programmes were not superior to minimal intervention. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016047939.
引用
- Karam G, Agarwal A, Sadeghirad B, et al. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis. BMJ. 2023. PMID: 36990505. doi:10.1136/bmj-2022-072003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。